Correspondence 0001104659-25-026198 from Evaxion A/S (EVAX)
Evaxion A/S
Date: March 20, 2025 · CIK: 0001828253 · Accession: 0001104659-25-026198
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285778
Letter
Office of Life Sciences Division of Corporation Finance Registration Statement on Form F-3 (File No. 333- 285778) Acceleration Request Requested Date: March 24, 2025 Requested Time: 4:30 P.M. Eastern Time
Dear Mr. Howes:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned registrant (the " Registrant ") hereby requests that the Securities and Exchange Commission (the " Commission ") take appropriate action to cause the above-referenced Registration Statement on Form F-3 (File No. 333-285778) (the "Registration Statement ") to become effective on Monday, March 24, 2025, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff (the " Staff ").
Once the Registration Statement has been declared effective, please orally confirm that event with Michael D. Baird of Duane Morris LLP by telephone at (215) 870-6771, or if you have any questions or require additional information regarding this matter. Thank you for your assistance and cooperation in this matter.
The Company understands that the Staff will consider this request as confirmation by the Company of its awareness of its responsibilities under the federal securities laws as they relate to the offering of the securities covered by the Registration Statement.
Very truly yours,
Evaxion Biotech A/S
Show Raw Text
CORRESP 1 filename1.htm Evaxion Biotech A/S Dr. Neergaards Vej 5F 2970 Hørsholm Denmark Telephone: +45 31 31 97 53 March 20, 2025 U.S. Securities and Exchange Commission Office of Life Sciences Division of Corporation Finance 100 F Street, N.E. Mail Stop 4546 Washington, D.C. 20549 Attn: Mr. Tyler Howes Re: Evaxion Biotech A/S Registration Statement on Form F-3 (File No. 333- 285778) Acceleration Request Requested Date: March 24, 2025 Requested Time: 4:30 P.M. Eastern Time Dear Mr. Howes: In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned registrant (the " Registrant ") hereby requests that the Securities and Exchange Commission (the " Commission ") take appropriate action to cause the above-referenced Registration Statement on Form F-3 (File No. 333-285778) (the "Registration Statement ") to become effective on Monday, March 24, 2025, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff (the " Staff "). Once the Registration Statement has been declared effective, please orally confirm that event with Michael D. Baird of Duane Morris LLP by telephone at (215) 870-6771, or if you have any questions or require additional information regarding this matter. Thank you for your assistance and cooperation in this matter. The Company understands that the Staff will consider this request as confirmation by the Company of its awareness of its responsibilities under the federal securities laws as they relate to the offering of the securities covered by the Registration Statement. Very truly yours, Evaxion Biotech A/S By: /s/ Christian Kanstrup Christian Kanstrup Chief Executive Officer cc: Michael D. Baird, Duane Morris LLP Lars Lüthjohan Jensen, Mazanati-Andersen 2